4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-21-062707
EVP, Research & CSO sold 1,375 shares at $36.94 ($50,793)
- EVP, Research & CSO acquired 1,375 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2021-11-02 | Option exercise | +1,375 | $1.53 | $2,104 | 109,075 | D: show line 1 in the form |
| Virgin Herbert EVP, Research & CSO | 2021-11-02 | Sale | −1,375 | $36.94 | $50,793 | 107,700 | D: show line 2 in the form |
| Open-market sales · 1,375 sh · avg $36.94 · $50,793 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2021-11-02 | Option exercise · Stock Option (Right to Buy) | −1,375 | 247,005 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…